Facebook Linkedin RSS Twitter Youtube
Home 2023

Lonza

Biopharma Taps Bioprocessing 4.0, Benefits Start Flowing
Bioprocessing

Biopharma Taps Bioprocessing 4.0, Benefits Start Flowing

Cell Culture Media System
New Products

Cell Culture Media System

Lonza Enters Bispecific Antibody Collaboration with ABL Bio
Bioprocessing

Lonza Enters Bispecific Antibody Collaboration with ABL Bio

Biomanufacturing Facility Upgrades at Catalent, Recipharm, and Lonza
News

Biomanufacturing Facility Upgrades at Catalent, Recipharm, and Lonza

Lonza Collaborates with Cristal Therapeutics and McSAF to Expand Bioconjugates Offering
Drug Discovery

Lonza Collaborates with Cristal Therapeutics and McSAF to Expand Bioconjugates Offering

Antibody Drug Conjugates Form Basis of Lonza and AbTis Collaboration
Bioprocessing

Antibody Drug Conjugates Form Basis of Lonza and AbTis Collaboration

Lonza Expands Multipurpose Suite
Bioprocessing

Lonza Expands Multipurpose Suite

Lonza and the Israel Biotech Fund Ink Development and Manufacturing Deal
Bioprocessing

Lonza and the Israel Biotech Fund Ink Development and Manufacturing Deal

Lonza and Integral Molecular Offer to Enhance Early De-Risking of Clients’ Biotherapeutics
Bioprocessing

Lonza and Integral Molecular Offer to Enhance Early De-Risking of Clients’ Biotherapeutics

Lonza Will Manufacture Asher Bio’s Cis-targeted IL-2 Fusion Protein
Bioprocessing

Lonza Will Manufacture Asher Bio’s Cis-targeted IL-2 Fusion Protein

123...14Page 1 of 14
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.